Source: Annual Congress 2013 –COPD treatment and others
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Kochetkova, L. Ugay, Y. Maistrovskaya, T. Sourovenko, G. Massard (Vladivostok, Russian Federation; Strasbourg, France). Adipokines and ghrelin in chronic obstructive pulmonary disease. Eur Respir J 2013; 42: Suppl. 57, 3659

Member's Comments

No comment yet.

Related content which might interest you: Systemic inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Osteoporosis and adipose tissue expression of adipokines and osteoprotegerin in severe chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Increased serum level of apelin in chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Systemic effects of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=224 Year: 2006 Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Systemic manifestations in smokers and mild/moderate chronic obstructive pulmonary disease Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease? Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Coronary calcium and epicardial adipose tissue in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Biomarkers in the management of COPD Source: Eur Respir Rev 2009; 18: 96-104 Year: 2009 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013